Sanofi Pasteur, Canada
Ali Azizi has received his Ph.D. from the Department of Microbiology and Immunology at University of Ottawa. After graduation, he joined National Research Council of Canada as a Post-doctoral Fellow. Following his fellowship, Ali joined Variation Biotechnologies and directed several pre-clinical vaccine studies in North America or Overseas. Afterwards, he joined the Department of Pathology and Laboratory Medicine at the University of Ottawa as an Adjunct (Assistant) Professor. In 2010, Ali joined Sanofi Pasteur, the largest vaccine company dedicated to the design and development of human vaccine. He is currently involved in several human vaccine phase trials. He is also acting as a part-time Lecturer at the University of Toronto. To date, Dr. Azizi has published over 20 scientific articles in peer-reviewed journals, authored a few books, and developed several international patents. He has been acting as a reviewer for several prestigious journals and international conferences. He is also served as a grant reviewer for several governmental organizations including CIHR.
Journal of Cytology & Histology received 1837 citations as per Google Scholar report